20Jun 2022
Exploring the genetic space of the DNA damage response for cancer therapy through CRISPR‐based screens

Exploring the genetic space of the DNA damage response for cancer therapy through CRISPR‐based screens

The concepts of synthetic lethality and viability have emerged as powerful approaches to identify vulnerabilities and resistances within the DNA damage response for the treatment of cancer. While such complex genetic interactions between genes have been studied extensively in model organisms, they have only recently been prioritized as therapeutic strategies due to technological advancements in genetic screens. Here, the study discusses synthetic lethal and viable interactions within the DNA damage response and presents how CRISPR‐based genetic screens and chemical compounds have allowed for the systematic identification and targeting of such interactions for cancer treatment.

  • #oncology

Like

Save

Share